Ledger.Open graph →
SEC Form D · Amendment · filed November 16, 2012

MethylGene Inc

Offering
$48.3M
Sold
$35.6M
Exemption
Industry
Biotechnology
Location
MONTREAL, Quebec, Canada
Type

People & firms on this filing (24)

Joseph Walewicz · Montreal, Quebec, CanadaExecCharles Baum · MONTREAL, Quebec, CanadaExec · DirectorArkadii Vaisburg · Montreal, Quebec, CanadaExecJeffrey M. Besterman · MONTREAL, Quebec, CanadaExecGregory Reid · Montreal, Quebec, CanadaExecMartin Godbout · MONTREAL, Quebec, CanadaExec · DirectorRodney W. Lappe · MONTREAL, Quebec, CanadaDirectorHenry J. Fuchs · MONTREAL, Quebec, CanadaDirectorPeggy Mulligan · MONTREAL, Quebec, CanadaDirectorKlaus B. Kepper · MONTREAL, Quebec, CanadaExecPeter Thompson · MONTREAL, Quebec, CanadaDirectorRachel Humphrey · Montreal, Quebec, CanadaExecPatrick J. Kerins · Chevy Chase, MDExec · DirectorJustin Burden · San Francisco, CADirectorDavid Mitchell · Reston, VADirectorFrederick R. Hofmeyr · Grand Cayman, Cayman IslandsDirectorJustin B. Clarke · Grand Cayman, Cayman IslandsExecAndrew P. Laver · Murray, UTExecSteve Eskenazi · Burlingame, CADirectorJ. A. Rogers · SEATTLE, WAExecKevin Ober · SEATTLE, WAExecAnthony Askew · SEATTLE, WAExecL. W. Hamrick, Iii · Charlotte, NCExec · DirectorJeffrey Meshel · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗